Table 2.1.
Asymptomatic Patients Without Known ASCVD
| Clinical Scenario Text | ECG Treadmill | Stress Nuclear MPI | Stress Echo | Stress CMR | CAC | CCTA | Cath | No Test | |
|---|---|---|---|---|---|---|---|---|---|
| 34. | Low ASCVD risk < 5%* | R (2) | R (1) | R (1) | R (1) | M (4) | R (1) | R (1) | A (8) |
| 35. | Borderline ASCVD risk 5% to 7.5% | M (4) | R (2) | R (2) | R (2) | A (7) | R (2) | R (1) | A (7) |
| 36. | Borderline ASCVD risk 5% to 7.5% with risk-enhancing factors† | M (4) | R (3) | R (3) | R (3) | A (7) | R (3) | R (1) | A (7) |
| 37. | Intermediate ASCVD risk 7.5% to 20% with or without risk-enhancing factors† | M (5) | R (3) | R (3) | R (3) | A (8) | R (3) | R (1) | M (5) |
| 38. | High ASCVD risk > 20% | M (5) | M (4) | M (4) | M (4) | M (6) | M (4) | R (2) | M (5) |
A = Appropriate; ASCVD = atherosclerotic cardiovascular disease; CAC = coronary artery calcium score; cath = cardiac catheterization; CCTA = coronary computed tomography angiography; CMR = cardiac magnetic resonance; ECG = electrocardiogram; echo = echocardiography; M = May Be Appropriate; MPI = myocardial perfusion imaging; R = Rarely Appropriate
*Risk calculated using the ASCVD risk estimator
†See Table C, Risk-Enhancing Factors